P3 Health Partners

Healthtech / value-based careUSA
πŸ“‰ Public < $1B
PeakΒ $2.3 BillionToday
~-97%
from peak
  1. πŸ¦„
    Became a unicorn
    2021
  2. πŸ“ˆ
    Peak valuation
    $2.3 Billion ’21
  3. πŸ’”
    Became a Unitard
    2022
  4. πŸ’Έ
    Last valuation
    ~$69M
Current status
Public (Nasdaq: PIII); market cap collapsed to ~$60M after its 2021 SPAC debut; faced delisting.

How it happened

P3 Health Partners is a value-based primary-care company managing Medicare Advantage patients under risk-based contracts, and it went public in December 2021 via a $2.3B SPAC merger with Foresight Acquisition Corp, with a PIPE backed by Fidelity and Janus Henderson. Heavy losses and the harsh economics of managed care battered the stock, which collapsed roughly 97% to a market value around $60M and faced Nasdaq delisting. Glassdoor reviews from the post-SPAC downturn described layoffs that landed in more than one round despite leadership's assurances that jobs were safe, often with little warning β€” alongside heavy turnover, frozen pay, and a 'People, Passion, Purpose' family messaging many felt rang hollow during the cuts.

Employee accounts paraphrase anonymous, unverified reviews posted publicly on Glassdoor β†—. See our methodology.

Source: GlobeNewswire / DealFlow / stockanalysis ($2.3B EV / $2.4B equity de-SPAC via Foresight Acquisition Corp Dec 2021, PIPE incl. Fidelity and Janus Henderson; stock fell to ~$62M market cap)

More from the club

πŸ¦„